A Japanese Multicenter Database Study of Retroperitoneal Sarcoma: Outcomes of Patients Receiving Eribulin Therapy

20260 citationsJournal Article

Authors

Makito Miyake · Nara Medical University

Yuki Oda · Nara Medical University

Nobutaka Nishimura · Nara Medical University

Motokiyo Yoshikawa

Keiichi Sakamoto · Nara City Hospital

Yoshiaki Matsumura · Nara City Hospital

Atsushi Tomioka · Jikei University Kashiwa hospital

Abstract

We separately described outcomes and treatment patterns of patients with resectable and unresectable RPS. Our findings suggest that eribulin should be considered a treatment option for unresectable RPS in clinical practice.

Topics & Keywords

Sarcoma Diagnosis and Treatment Cancer Research and Treatments Gastrointestinal Tumor Research and Treatment

UN Sustainable Development Goals

Zero hunger

Publication Details

Published in: Asia-Pacific Journal of Clinical Oncology

DOI: 10.1111/ajco.70080

Field-Weighted Citation Impact: 0.00